Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA UROLOGY LASER MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 IMPORT-EXPORT ANALYSIS
4.3.1 IMPORT
4.3.2 EXPORT
4.4 STRATEGIC INITIATIVES
4.5 PRICING ANALYSIS
4.6 ADOPTION OF LASER
5 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, EPIDEMIOLOGY
5.1 INCIDENCE AND PREVALENCE OF UROLOGY DISORDERS, BY COUNTRY
5.2 UROLITHIASIS
5.3 BENIGN PROSTATIC HYPERPLASIA (BPH)
5.4 PARTIAL KIDNEY RESECTION
5.5 KIDNEY STONES
5.6 URETHRAL STRICTURES
5.7 TUMORS
6 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN THE U.S.
6.2 REGULATORY SCENARIO IN AUSTRALIA
6.3 REGULATORY SCENARIO IN INDIA
6.4 REGULATORY SCENARIO IN U.K.
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING NUMBER OF PATIENTS RELATED TO UROLOGY DISORDERS MIDDLE EAST & AFRICALY
7.1.2 INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES
7.1.3 RISE IN THE NUMBER OF PRODUCT APPROVAL FOR LASER DEVICES
7.1.4 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR UROLOGY LASER DEVICES
7.2 RESTRAINTS
7.2.1 HIGH COST OF UROLOGY LASER DEVICE AND PROCEDURE
7.2.2 SAFETY CONCERNS AND ADVERSE EFFECTS ASSOCIATED WITH LASER PROCEDURES SAFETY CONCERNS
7.2.3 LACK OF AWARENESS ABOUT TREATMENT FOR UROLOGICAL CONDITIONS
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN LASER TECHNOLOGY
7.3.2 STRATEGIC INITIATIVES BY EMERGING PLAYERS
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS
7.4.2 STRINGENT REGULATIONS
8 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY LASER TYPE
8.1 OVERVIEW
8.2 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
8.3 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
8.4 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
8.5 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
8.6 DIODE LASER
8.7 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
8.8 LITHIUM BORATE
8.9 OTHERS
9 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY MODALITY
9.1 OVERVIEW
9.2 PORTABLE
9.3 STANDALONE
10 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 UROLITHIASIS
10.2.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.2.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.2.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.2.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.2.5 DIODE LASER
10.2.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.2.7 LITHIUM BORATE
10.2.8 OTHERS
10.3 BENIGN PROSTATIC HYPERPLASIA (BPH)
10.3.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.3.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.3.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.3.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.3.5 DIODE LASER
10.3.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.3.7 LITHIUM BORATE
10.3.8 OTHERS
10.4 PARTIAL KIDNEY RESECTION
10.4.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.4.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.4.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.4.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.4.5 DIODE LASER
10.4.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.4.7 LITHIUM BORATE
10.4.8 OTHERS
10.5 REMOVAL OF KIDNEY STONES
10.5.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.5.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.5.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.5.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.5.5 DIODE LASER
10.5.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.5.7 LITHIUM BORATE
10.5.8 OTHERS
10.6 URETHRAL STRICTURES
10.6.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.6.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.6.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.6.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.6.5 DIODE LASER
10.6.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.6.7 LITHIUM BORATE
10.6.8 OTHERS
10.7 TUMORS
10.7.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.7.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.7.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.7.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.7.5 DIODE LASER
10.7.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.7.7 LITHIUM BORATE
10.7.8 OTHERS
10.8 OTHERS
10.8.1 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG)
10.8.2 THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG)
10.8.3 NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG)
10.8.4 POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG)
10.8.5 DIODE LASER
10.8.6 ERBIUM: YTTRIUM ALUMINUM GARNET LASER
10.8.7 LITHIUM BORATE
10.8.8 OTHERS
11 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 UROLOGICAL CLINICS
11.4 AMBULATORY SURGICAL CENTERS
11.5 OTHERS
12 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 ONLINE SALES
12.5 OTHERS
13 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY REGION
13.1 MIDDLE EAST AND AFRICA
13.1.1 SOUTH AFRICA
13.1.2 SAUDI ARABIA
13.1.3 U.A.E.
13.1.4 ISRAEL
13.1.5 EGYPT
13.1.6 KUWAIT
13.1.7 QATAR
13.1.8 NIGERIA
13.1.9 REST OF MIDDLE EAST AND AFRICA
14 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BOSTON SCIENTIFIC CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 COOK
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 OLYMPUS CORPORATION
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 COHERENT, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 DORNIER MEDTECH
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ADVIN HEALTH CARE
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ALLENGERS
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BD
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BIOLITEC AG
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BISON MEDICAL
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CONVERGENT LASER TECHNOLOGIES
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 EMS UROLOGY
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 GIGAALASER
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 HEALTHWARE PVT LTD.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 HYPERPHOTONICS.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 INTERMEDIC ARFRAN
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 LIMMER LASER GMBH
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 MONOCROM
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 OMNIGUIDE HOLDINGS, INC.
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 POTENT MEDICAL.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 QUANTA SYSTEM
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 RICHARD WOLF GMBH.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
16.23 ROCAMED
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 SURGICAL LASERS INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 TRIMEDYNE, INC.
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 UNIQUE MEDICAL DEVICES
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 IN 2022, ACCORDING TO THE ARTICLE PUBLISHED BY ELSEVIER LTD, THE FOLLOWING WAS THE DATA ON THE PREVALENCE AND INCIDENT RATES OF BPH IN 2019
TABLE 2 FOLLOWING TABLES SHOW TOTAL MIDDLE EAST & AFRICA KIDNEY CANCER INCIDENCE AND RATES IN 2020 FOR COUNTRIES WITH THE HIGHEST RATES OF KIDNEY CANCER/TUMORS.
TABLE 3 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY LASER TYPE, 2021-2030 (USD THOUSAND)
TABLE 4 MIDDLE EAST & AFRICA HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 MIDDLE EAST & AFRICA THULIUM YTTRIUM ALUMINUM GARNET (THU:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 MIDDLE EAST & AFRICA NEODYMIUM-DOPED YTTRIUM ALUMINUM GARNET (ND:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 MIDDLE EAST & AFRICA POTASSIUM TITANYL PHOSPHATE YTTRIUM ALUMINUM GARNET (KTP:YAG) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 MIDDLE EAST & AFRICA DIODE LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 MIDDLE EAST & AFRICA ERBIUM: YTTRIUM ALUMINUM GARNET LASER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 MIDDLE EAST & AFRICA LITHIUM BORATE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 MIDDLE EAST & AFRICA OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY MODALITY, 2021-2030 (USD THOUSAND)
TABLE 13 MIDDLE EAST & AFRICA PORTABLE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 MIDDLE EAST & AFRICA STANDALONE IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 15 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY APPLICATION 2021-2030 (USD THOUSAND)
TABLE 16 MIDDLE EAST & AFRICA UROLITHIASIS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 MIDDLE EAST & AFRICA UROLITHIASIS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 18 MIDDLE EAST & AFRICA BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 MIDDLE EAST & AFRICA BENIGN PROSTATIC HYPERPLASIA (BPH) IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 20 MIDDLE EAST & AFRICA PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 MIDDLE EAST & AFRICA PARTIAL KIDNEY RESECTION IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 22 MIDDLE EAST & AFRICA REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 23 MIDDLE EAST & AFRICA REMOVAL OF KIDNEY STONES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 24 MIDDLE EAST & AFRICA URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 MIDDLE EAST & AFRICA URETHRAL STRICTURES IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 26 MIDDLE EAST & AFRICA TUMORS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 MIDDLE EAST & AFRICA TUMORS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 MIDDLE EAST & AFRICA OTHERS IN UROLOGY LASER MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 30 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 31 MIDDLE EAST & AFRICA HOSPITALS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 MIDDLE EAST & AFRICA UROLOGICAL CLINICS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 34 MIDDLE EAST & AFRICA OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 MIDDLE EAST & AFRICA UROLOGY LASER MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 36 MIDDLE EAST & AFRICA DIRECT TENDER IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 MIDDLE EAST & AFRICA RETAIL SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 MIDDLE EAST & AFRICA ONLINE SALES IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 MIDDLE EAST & AFRICA OTHERS IN UROLOGY LASER MARKET, BY REGION, 2021-2030 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: MIDDLE EAST & AFRICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: MULTIVARIATE MODELLING
FIGURE 8 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: MARKET END USER COVERAGE GRID
FIGURE 11 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: SEGMENTATION
FIGURE 12 RISING NUMBER OF PATIENT RELATED TO UROLOGY DISORDER AND I INCREASED INCLINATION TOWARDS NON-INVASIVE SURGERIES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA UROLOGY LASER MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 HOLMIUM YTTRIUM ALUMINUM GARNET (HO:YAG) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA UROLOGY LASER MARKET IN 2023 & 2030
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA UROLOGY LASER MARKET
FIGURE 15 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY LASER TYPE, 2022
FIGURE 16 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY LASER TYPE, 2023-2030 (USD THOUSAND)
FIGURE 17 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY LASER TYPE, CAGR (2023-2030)
FIGURE 18 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY LASER TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY MODALITY, 2022
FIGURE 20 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY MODALITY, 2023-2030 (USD THOUSAND)
FIGURE 21 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY MODALITY, CAGR (2023-2030)
FIGURE 22 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY APPLICATION, 2022
FIGURE 24 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 25 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 26 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY END USER, 2022
FIGURE 28 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 29 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY END USER, CAGR (2023-2030)
FIGURE 30 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 32 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 33 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 34 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA UROLOGY LASER MARKET: SNAPSHOT (2022)
FIGURE 36 MIDDLE EAST AND AFRICA UROLOGY LASER MARKET: BY COUNTRY (2022)
FIGURE 37 MIDDLE EAST AND AFRICA UROLOGY LASER MARKET: BY COUNTRY (2023 & 2030)
FIGURE 38 MIDDLE EAST AND AFRICA UROLOGY LASER MARKET: BY COUNTRY (2022 & 2030)
FIGURE 39 MIDDLE EAST AND AFRICA UROLOGY LASER MARKET: BY LASER TYPE (2023-2030)
FIGURE 40 MIDDLE EAST & AFRICA UROLOGY LASER MARKET: COMPANY SHARE 2022 (%)
